168 related articles for article (PubMed ID: 30364858)
1.
Maruyama S; Furuya S; Shiraishi K; Shimizu H; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
World J Gastrointest Oncol; 2018 Oct; 10(10):344-350. PubMed ID: 30364858
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of claudin-18.2 in alpha-fetoprotein-producing gastric cancer compared to conventional gastric cancer.
Weng W; Zhang M; Ni S; Tan C; Xu M; Wang X; Sun H; Wang L; Huang D; Sheng W
J Gastrointest Oncol; 2022 Jun; 13(3):1035-1045. PubMed ID: 35837176
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.
Liu D; Li B; Yan B; Liu L; Jia Y; Wang Y; Ma X; Yang F
Int J Clin Exp Pathol; 2020; 13(9):2439-2446. PubMed ID: 33042357
[TBL] [Abstract][Full Text] [Related]
4. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
5. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
[TBL] [Abstract][Full Text] [Related]
6. Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to
Lee JW; Kim N; Park JH; Kim HJ; Chang H; Kim JM; Kim JW; Lee DH
J Cancer Prev; 2017 Mar; 22(1):33-39. PubMed ID: 28382284
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.
He R; Yang Q; Dong X; Wang Y; Zhang W; Shen L; Zhang Z
Oncotarget; 2017 Apr; 8(14):23817-23830. PubMed ID: 28423604
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
Wang R; Li J; Xu D; Li R; Gong P
Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
[TBL] [Abstract][Full Text] [Related]
9. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
Zuo CT; Ju Q
Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
[TBL] [Abstract][Full Text] [Related]
10. Recurrent metastatic patterns and prognosis after radical surgery in patients with alpha-fetoprotein-producing gastric cancer: a retrospective cohort study.
Zhang F; Zhang X; Zhang X; Wang Y; Li T; Guo H; Ding P; Tian Y; Yang P; Li X; Meng N; Guo Z; Zhao Q; Zhang R
Am J Cancer Res; 2024; 14(5):2124-2140. PubMed ID: 38859826
[TBL] [Abstract][Full Text] [Related]
11. The Relationship Between D-dimer and Prognosis in the Patients with Serum Alpha-Fetoprotein-Positive Gastric Cancer: A Retrospective Cohort Study.
Zhang X; Wang W; Tian B; Wang Y; Jing J
Clin Med Insights Oncol; 2022; 16():11795549221120158. PubMed ID: 36104997
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of the prognosis of alpha-fetoprotein-producing gastric cancer from a single center: a case series study.
Akabane M; Yago A; Haruta S; Ohkura Y; Ueno M; Udagawa H
Langenbecks Arch Surg; 2023 Jan; 408(1):66. PubMed ID: 36695913
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Gong W; Su Y; Liu A; Liu J; Sun D; Jiang T; Xiang J; Chi C; Sun P
Neoplasma; 2018 Mar; 65(3):326-330. PubMed ID: 29788728
[TBL] [Abstract][Full Text] [Related]
14. Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
Arakawa Y; Tamura M; Aiba K; Morikawa K; Aizawa D; Ikegami M; Yuda M; Nishikawa K
Oncol Lett; 2017 Sep; 14(3):3039-3042. PubMed ID: 28928842
[TBL] [Abstract][Full Text] [Related]
15. Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer.
Mei Y; Li M; Wen J; Kong X; Li J
Cancer Med; 2023 May; 12(10):12018-12033. PubMed ID: 37017469
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma.
Zhang Z; Ge S; Wang X; Yuan Q; Yan Q; Ye H; Che Y; Lin Y; Zhang J; Liu P
Hepatol Int; 2013 Mar; 7(1):199-207. PubMed ID: 26201634
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.
Cao Y; Tan S; Tu Y; Zhang G; Liu Y; Li D; Xu S; Le Z; Xiong J; Zou W; Gong P; Li Z; Jie Z
Oncol Lett; 2018 Apr; 15(4):5119-5130. PubMed ID: 29552146
[TBL] [Abstract][Full Text] [Related]
18. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated microRNA expression profiles in gastric cancer cells with high peritoneal metastatic potential.
Feng Y; Bai F; You Y; Bai F; Wu C; Xin R; Li X; Nie Y
Exp Ther Med; 2018 Dec; 16(6):4602-4608. PubMed ID: 30546395
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
